Investing.com - Takeda Pharma ADR reported on Thursday third quarter earnings that missed analysts' forecasts and revenue that topped expectations.
Takeda Pharma ADR announced earnings per share of ¥-0.048 on revenue of ¥7.43B. Analysts polled by Investing.com anticipated EPS of ¥0.232 on revenue of ¥7.4B.
Takeda Pharma ADR shares are down 24.07% from the beginning of the year, still down 30.76% from its 52 week high of ¥19.96 set on March 22. They are under-performing the EUR/USD which is down 0% from the start of the year.
Takeda Pharma ADR shares gained 2.17% in pre-market trade following the report.
Takeda Pharma ADR follows other major Healthcare sector earnings this month
Takeda Pharma ADR's report follows an earnings beat by Merck&Co on Thursday, who reported EPS of ¥1.75 on revenue of ¥13.15B, compared to forecasts EPS of ¥1.54 on revenue of ¥12.26B.
Hoya Corp had beat expectations on Thursday with third quarter EPS of ¥1.02 on revenue of ¥1.43B, compared to forecast for EPS of ¥0.9772 on revenue of ¥1.42B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar